Endoscopic Mucosal Resection Market Size, Share, Growth, and Industry Analysis, By Type (Entry Needle, Mucosectomy Snare, Probe, and Other), By Application (Hospitals, Ambulatory Surgical Centers, Surgical Centers, Others), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

ENDOSCOPIC MUCOSAL RESECTION MARKET OVERVIEW

Starting at USD 2.37 Billion in 2026, the global Endoscopic Mucosal Resection Market is set to witness notable growth. By 2035, it is projected to reach USD 4.7 Billion. The market is expected to expand at a CAGR of 7.9% throughout the forecast period from 2026 to 2035.

The Endoscopic Mucosal Resection Market is expanding due to increasing adoption of minimally invasive gastrointestinal procedures, rising diagnosis of early-stage gastrointestinal cancers, and advancements in endoscopic technologies. Endoscopic mucosal resection is widely used for removing abnormal tissues from the digestive tract, especially lesions in the esophagus, stomach, and colon. Approximately 90% of early gastrointestinal lesions can be evaluated through advanced endoscopic techniques, improving treatment accessibility. The market is influenced by rising demand for disposable accessories, precision-based devices, and improved visualization systems. Increasing healthcare infrastructure investments and adoption of advanced endoscopy equipment are supporting the Endoscopic Mucosal Resection Market Research Report landscape.

The USA Endoscopic Mucosal Resection Market is supported by increasing gastrointestinal disease screening programs, advanced healthcare facilities, and growing preference for non-surgical treatment approaches. More than 60 million Americans experience digestive disorders annually, creating demand for advanced diagnostic and therapeutic endoscopy procedures. Colorectal cancer screening programs beginning around age 45 years have increased procedure volumes, while approximately 40% of gastrointestinal cancers are detected at early stages where endoscopic intervention can be considered. Hospitals and ambulatory surgical centers in the USA are increasingly adopting advanced mucosal resection devices, including snares, injection needles, and electrosurgical systems, strengthening market growth.

KEY FINDINGS

LATEST TRENDS

Enhanced Imaging Capabilities to Broaden Market Growth

The Endoscopic Mucosal Resection Market Trends are strongly influenced by technological advancements, rising gastrointestinal cancer screening, and increasing adoption of minimally invasive treatment methods. Endoscopic mucosal resection procedures have become an important alternative to conventional surgical methods because they reduce patient recovery periods and minimize procedural complications. Approximately 75% of gastroenterology departments prioritize minimally invasive approaches for early-stage lesions due to improved patient outcomes. Advanced imaging technologies are becoming a significant trend in the Endoscopic Mucosal Resection Industry Analysis, with approximately 55% of healthcare facilities adopting enhanced visualization systems to identify abnormal tissue boundaries more accurately. High-definition imaging, narrow-band imaging, and improved endoscopic accessories are supporting better clinical decision-making.

Disposable endoscopic accessories are gaining importance, with nearly 60% of hospitals preferring single-use products to reduce infection risks and improve procedural safety. Increasing demand for injection needles, mucosectomy snares, and electrosurgical devices is shaping the Endoscopic Mucosal Resection Market Outlook. The rising prevalence of colorectal, gastric, and esophageal cancers is another major factor influencing the Endoscopic Mucosal Resection Market Forecast. Globally, colorectal cancer represents approximately 10% of newly diagnosed cancer cases, increasing demand for early detection and tissue removal procedures. Healthcare providers are also focusing on training programs, with approximately 40% of emerging healthcare facilities investing in advanced endoscopy skill development.

• According to the American Cancer Society, approximately 106,590 new cases of colon cancer were diagnosed in the U.S. in 2024, promoting wider adoption of EMR techniques for early-stage tumor removal.
• As per a study published by the National Institutes of Health (NIH), EMR has shown a 91% complete resection rate in early gastrointestinal neoplasia, reinforcing its growing preference over invasive surgeries.

Download Free Sample to learn more about this report

ENDOSCOPIC MUCOSAL RESECTION MARKET SEGMENTATION

By Type

Based on type, the market is divided into entry needle, mucosectomy snare, probe, and other.

• Entry Needle: The Entry Needle segment plays an important role in the Endoscopic Mucosal Resection Market due to its application in submucosal injection procedures before tissue removal. Entry needles are used to inject lifting solutions beneath lesions, creating a safety layer between abnormal tissue and deeper gastrointestinal layers. Approximately 25% of endoscopic mucosal resection procedures require specialized injection needles for effective lesion elevation and improved procedural accuracy. Demand for entry needles is increasing as physicians focus on reducing perforation risks and improving patient safety. Around 40% of gastroenterologists consider submucosal lifting techniques essential for successful mucosal resection procedures. Manufacturers are developing improved needle designs with enhanced flexibility, precision control, and better injection performance.

• Mucosectomy Snare: The Mucosectomy Snare segment holds a leading position in the Endoscopic Mucosal Resection Market due to its direct application in tissue cutting and removal. Mucosectomy snares are among the most widely used accessories during endoscopic resection procedures, accounting for approximately 40% of accessory demand. These devices are designed to capture and remove abnormal mucosal tissues while minimizing damage to surrounding structures. Increasing adoption of disposable snares is a major trend, with approximately 60% of hospitals preferring single-use products to reduce infection risks and maintain procedural consistency.

• Probe: The Probe segment contributes to the Endoscopic Mucosal Resection Market through applications involving tissue assessment, lesion identification, and procedural assistance. Probes help physicians evaluate treatment areas and improve precision during endoscopic procedures. Approximately 20% of advanced endoscopy units utilize specialized probe technologies to support diagnostic and therapeutic applications. Increasing demand for accurate lesion evaluation is driving adoption of improved probe systems. Around 35% of healthcare providers emphasize the importance of enhanced visualization and tissue assessment technologies in gastrointestinal procedures.

• Other Accessories: The Other Accessories segment includes injection systems, electrosurgical components, retrieval devices, and supporting tools used during endoscopic mucosal resection procedures. This segment accounts for approximately 15% of accessory demand and continues to expand due to increasing procedural complexity. Healthcare providers require multiple supporting instruments to improve safety, efficiency, and treatment accuracy. Around 45% of endoscopy centers use multiple accessory categories during advanced mucosal resection procedures. Manufacturers are focusing on developing integrated accessory solutions that improve compatibility with different endoscopic platforms. Approximately 35% of product development activities involve improving accessory performance, durability, and ease of use.

By Application

Based on application, the market is bifurcated into hospitals, ambulatory surgical centers, surgical centers.

• Hospitals: Hospitals represent the largest application segment in the Endoscopic Mucosal Resection Market, accounting for approximately 55% of total procedure utilization. Hospitals dominate due to advanced medical infrastructure, availability of specialized gastroenterologists, and access to comprehensive diagnostic facilities. Large hospitals perform a significant number of gastrointestinal procedures annually, including colorectal lesion removal, gastric lesion treatment, and esophageal interventions. Approximately 70% of complex endoscopic procedures are performed in hospital-based facilities because of their ability to manage advanced cases and potential complications.

• Ambulatory Surgical Centers: Ambulatory surgical centers are becoming an important application segment in the Endoscopic Mucosal Resection Market Research Report due to increasing preference for outpatient procedures. These centers account for approximately 30% of procedure adoption, particularly for patients requiring less complex mucosal resection treatments. The growth of ambulatory facilities is supported by demand for cost-effective healthcare delivery and shorter patient recovery periods. Approximately 45% of patients prefer outpatient treatment options when clinically appropriate due to reduced waiting times and convenience.

• Surgical Centers: Surgical centers contribute approximately 15% of the Endoscopic Mucosal Resection Market demand. These facilities provide specialized treatment environments for patients requiring advanced gastrointestinal interventions combined with surgical support capabilities. Surgical centers are adopting endoscopic mucosal resection techniques because they offer minimally invasive alternatives compared with conventional surgical procedures. Approximately 40% of specialized surgical centers are expanding their therapeutic endoscopy services.

MARKET DYNAMICS

Driving Factor

Rising prevalence of gastrointestinal cancers and increasing adoption of minimally invasive procedures.

The increasing incidence of gastrointestinal disorders is one of the major factors driving the Endoscopic Mucosal Resection Market Growth. Gastrointestinal cancers represent approximately 26% of global cancer cases, creating significant demand for early diagnosis and therapeutic intervention methods. Endoscopic mucosal resection allows physicians to remove abnormal tissues without major surgery, improving patient recovery outcomes.

Increasing awareness regarding preventive screening is also supporting market expansion. Approximately 65% of healthcare professionals recommend regular gastrointestinal screening for high-risk populations. The growing elderly population, which has a higher risk of colorectal and gastric disorders, is further increasing procedure demand.

• According to the World Health Organization (WHO), gastrointestinal cancers account for over 35% of all cancer-related deaths globally, pushing the demand for early detection and removal procedures like EMR.
• The U.S. Preventive Services Task Force recommends colorectal screening from age 45, which adds roughly 21 million more individuals in the U.S. alone to the target demographic for EMR procedures.

RESTRAINING FACTORS

High equipment costs and requirement for specialized clinical expertise.

The Endoscopic Mucosal Resection Market Analysis identifies cost-related challenges as a major limitation affecting adoption, particularly in developing regions. Advanced endoscopic systems require significant investment in equipment, maintenance, and specialized accessories. Approximately 45% of healthcare providers consider the initial cost of advanced endoscopy equipment a major barrier.

The procedure also requires highly trained professionals with expertise in gastrointestinal endoscopy techniques. Around 35% of healthcare institutions report shortages of experienced endoscopists, limiting widespread implementation. Training requirements, procedural complexity, and additional costs associated with staff development create challenges for smaller hospitals.

• According to the NIH, the recurrence rate after EMR for large polyps can reach up to 20%, raising concerns regarding long-term treatment effectiveness in certain patient groups.
• As per the European Society of Gastrointestinal Endoscopy (ESGE), EMR procedures have a perforation risk of 1.4% and bleeding risk of 6.1%, leading to hesitation among low-volume healthcare centers.

Expansion of minimally invasive healthcare technologies and emerging healthcare infrastructure.

Opportunity

The Endoscopic Mucosal Resection Market Opportunities are increasing due to growing healthcare modernization and rising demand for minimally invasive treatments. Approximately 60% of hospitals worldwide are focusing on upgrading diagnostic and therapeutic endoscopy capabilities to improve patient care. Emerging economies are creating significant opportunities due to increasing healthcare investments and improving access to advanced medical procedures. Around 40% of new healthcare facilities in developing regions are incorporating advanced endoscopy units as part of their infrastructure development plans.

Procedural complexity and limited accessibility in developing healthcare regions.

Challenge

The Endoscopic Mucosal Resection Industry Report highlights procedural complexity as a significant challenge affecting market expansion. Unlike basic endoscopic examinations, mucosal resection requires advanced technical skills, precise tissue identification, and careful management of possible complications. Approximately 40% of healthcare professionals identify operator experience as a critical factor influencing treatment outcomes. Limited healthcare infrastructure remains another challenge in several regions. Around 35% of hospitals in developing markets lack access to advanced endoscopic equipment, restricting patient access to specialized procedures.

•   
•   
  Download Free Sample to learn more about this report

    

ENDOSCOPIC MUCOSAL RESECTION MARKET REGIONAL INSIGHTS

• North America

North America dominates the Endoscopic Mucosal Resection Market Share, contributing approximately 38% of global demand. The region benefits from highly developed healthcare infrastructure, widespread availability of therapeutic endoscopy units, and increasing awareness regarding early gastrointestinal cancer diagnosis. More than 60 million adults in the region experience digestive disorders annually, creating substantial demand for advanced diagnostic and therapeutic procedures.

Colorectal cancer screening initiatives have significantly increased the number of endoscopic procedures. Screening commonly begins at 45 years of age for average-risk adults, leading to earlier detection of precancerous lesions and improved treatment opportunities through endoscopic mucosal resection. Approximately 70% of tertiary hospitals have dedicated therapeutic endoscopy departments equipped with advanced visualization technologies and electrosurgical systems.

• Europe

Europe represents approximately 24% of the global Endoscopic Mucosal Resection Market, supported by well-established public healthcare systems and organized gastrointestinal cancer screening programs. Countries including Germany, France, Italy, Spain, and the United Kingdom continue expanding preventive healthcare initiatives aimed at early cancer diagnosis. Approximately 65% of colorectal cancer cases in several European countries are identified through organized screening or surveillance programs, increasing demand for minimally invasive therapeutic interventions. Hospitals across the region are integrating high-definition endoscopy systems, narrow-band imaging, and advanced mucosal resection accessories into routine clinical practice. Around 55% of European tertiary hospitals maintain specialized gastrointestinal endoscopy units capable of performing advanced therapeutic procedures. Healthcare providers increasingly prefer endoscopic treatment because it minimizes hospitalization time, lowers complication risks, and improves patient recovery compared with conventional surgery.

Medical device innovation remains strong throughout Europe. Approximately 45% of newly installed therapeutic endoscopy platforms include enhanced imaging software and precision electrosurgical systems. Academic institutions continue providing advanced training programs for gastroenterologists, increasing procedural expertise across the region. Government support for cancer prevention initiatives and modernization of hospital infrastructure continue strengthening the Endoscopic Mucosal Resection Market Growth across Europe. Increasing demand for outpatient gastrointestinal procedures is also encouraging healthcare facilities to expand their endoscopy service capabilities.

• Asia-Pacific

Asia-Pacific accounts for approximately 32% of the global Endoscopic Mucosal Resection Market, making it the fastest-expanding regional market in terms of procedural adoption. Rapid urbanization, increasing healthcare expenditure, aging populations, and higher awareness of gastrointestinal diseases are supporting market expansion throughout China, Japan, India, South Korea, and Australia. Japan remains one of the leading countries for advanced endoscopic procedures due to early adoption of minimally invasive gastrointestinal treatment technologies. Approximately 75% of major Japanese hospitals routinely perform advanced endoscopic interventions for early-stage gastrointestinal lesions. China is rapidly expanding hospital infrastructure, with nearly 50% of newly developed tertiary healthcare facilities incorporating advanced endoscopy departments.

India is witnessing increasing demand for therapeutic endoscopy because of rising digestive disease prevalence and expanding private healthcare investments. Around 40% of metropolitan hospitals have upgraded endoscopy suites with high-definition imaging systems and advanced mucosal resection accessories. The region also benefits from increasing physician training and government initiatives supporting cancer screening programs. Approximately 55% of newly trained gastroenterologists receive specialized education in therapeutic endoscopy techniques. Growing medical tourism and improved healthcare accessibility continue strengthening the Endoscopic Mucosal Resection Industry Analysis throughout Asia-Pacific.

• Middle East & Africa

The Middle East & Africa region contributes approximately 6% of the global Endoscopic Mucosal Resection Market, supported by gradual healthcare modernization, increasing investment in specialty hospitals, and growing awareness regarding gastrointestinal diseases. Although adoption remains lower than other regions, healthcare infrastructure continues improving across major countries. Countries such as the United Arab Emirates, Saudi Arabia, and South Africa are expanding tertiary healthcare facilities equipped with advanced endoscopy technologies. Approximately 35% of newly established specialty hospitals in the Gulf region include dedicated gastroenterology departments with therapeutic endoscopy capabilities.

Governments are increasing healthcare expenditure to improve access to minimally invasive procedures and reduce dependence on overseas treatment. Around 30% of healthcare modernization projects include investments in diagnostic and therapeutic endoscopy equipment. Private healthcare providers are also expanding specialized gastrointestinal services to meet growing patient demand. Training initiatives remain an important priority across the region. Approximately 40% of specialist gastroenterology centers collaborate with international medical institutions to improve physician expertise in advanced endoscopic procedures. Increasing awareness regarding colorectal cancer screening and digestive disease diagnosis is expected to improve procedure volumes over the coming years.

KEY INDUSTRY PLAYERS

Market Players Focus on New Product Launches to Strengthen Market Position

Leading players in the market are adopting various strategies to expand their presence in the market. These include R&D investments and launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.   

• CONMED: As per company filings, CONMED’s endoscopic portfolio is used in more than 100 countries, with its EMR devices being applied in over 250,000 procedures annually across global hospitals.
• Boston Scientific Corp.: According to internal data, Boston Scientific has trained over 8,000 gastroenterologists in EMR techniques and offers 30+ specialized tools designed for endoluminal lesion removal.

List of Top Endoscopic Mucosal Resection Companies

• CONMED [U.S.]
• Boston Scientific Corp. [U.S.]
• Cook Medical [U.S.]
• Erbe Elektromedizin GmbH [Germany]
• Interscope Medical [U.S.]
• Olympus [Japan]
• STERIS [U.S.]
• Sumitomo Bakelite Co., Ltd. [Japan]

TOP 2 COMPANIES WITH HIGHEST MARKET SHARE

• Olympus: holds the largest share of the Endoscopic Mucosal Resection Market, accounting for approximately 31% of the global market.

• Boston Scientific Corp.: represents the second-largest market participant with an estimated 22% market share.

INVESTMENT ANALYSIS AND OPPORTUNITIES

The Endoscopic Mucosal Resection Market continues to attract investment due to increasing demand for minimally invasive gastrointestinal treatments, growing incidence of digestive tract cancers, and continuous technological innovation. Approximately 62% of global healthcare investments in gastrointestinal care are directed toward upgrading diagnostic and therapeutic endoscopy capabilities. Hospitals are expanding dedicated endoscopy suites, while nearly 58% of tertiary medical centers have increased procurement of advanced endoscopic visualization systems and therapeutic accessories. Medical device manufacturers are allocating approximately 45% of their research budgets toward improving disposable accessories, precision electrosurgical instruments, and high-definition imaging technologies. Increasing adoption of artificial intelligence-assisted lesion detection has created new opportunities, with nearly 35% of recently introduced endoscopy platforms incorporating AI-supported visualization features.

Emerging economies present substantial opportunities within the Endoscopic Mucosal Resection Market Outlook. Around 48% of newly established specialty hospitals across Asia-Pacific and Latin America are investing in advanced therapeutic endoscopy equipment. Government-supported colorectal cancer screening programs are further increasing demand for mucosal resection procedures. Partnerships between hospitals, medical universities, and technology manufacturers are accelerating physician training initiatives. Approximately 40% of teaching hospitals have expanded simulation-based endoscopy education programs. Growing preference for outpatient procedures, increased adoption of disposable devices, and continuous healthcare modernization are expected to generate long-term investment opportunities across developed and emerging healthcare markets.

NEW PRODUCT DEVELOPMENT

Product innovation remains a key growth factor in the Endoscopic Mucosal Resection Market, with manufacturers focusing on precision, procedural safety, and physician convenience. Approximately 55% of recently introduced products feature enhanced ergonomic designs that improve maneuverability during therapeutic endoscopy. New-generation mucosectomy snares utilize thinner yet stronger wire configurations, improving tissue capture while reducing procedural complications.

Advanced injection needles with improved flow control and reinforced tip structures account for nearly 30% of current product development activities. These devices provide more consistent submucosal lifting and enhance lesion separation before tissue removal. Manufacturers are also introducing multi-functional accessories capable of reducing instrument exchanges during procedures, improving clinical efficiency. Artificial intelligence integration is emerging as an important innovation area. Nearly 38% of advanced endoscopic platforms now support AI-assisted lesion recognition, helping physicians identify abnormal mucosal patterns with greater accuracy. Enhanced imaging technologies, including high-definition visualization and optical image enhancement systems, continue improving procedural precision.

FIVE RECENT DEVELOPMENTS (2023-2025)

• February 2023: Olympus introduced an advanced therapeutic endoscopy platform featuring enhanced high-definition visualization and improved compatibility with endoscopic mucosal resection accessories. The system was designed to improve lesion detection accuracy, procedural precision, and physician workflow while supporting minimally invasive gastrointestinal treatment across specialized healthcare facilities.
• July 2023: Boston Scientific Corp. launched an expanded portfolio of disposable endoscopic snares and tissue retrieval devices for endoscopic mucosal resection procedures. The initiative focused on improving procedural efficiency, minimizing infection risks, and enhancing tissue capture performance during gastrointestinal interventions.
• March 2024: CONMED unveiled upgraded electrosurgical technology specifically designed for advanced gastrointestinal endoscopy. The new platform improved energy delivery precision, reduced thermal tissue damage, and enhanced compatibility with therapeutic endoscopic accessories, supporting safer mucosal resection procedures.
• September 2024: Cook Medical expanded its gastrointestinal intervention portfolio by introducing next-generation endoscopic injection needles with enhanced flow control and improved flexibility. The development aimed to increase procedural safety, optimize submucosal lifting performance, and support accurate lesion removal during complex endoscopic interventions.
• January 2025: Erbe Elektromedizin GmbH developed an advanced electrosurgical workstation integrating intelligent energy management for therapeutic endoscopy applications. The platform improved procedural consistency, supported multiple endoscopic treatment techniques, and strengthened clinical efficiency for advanced gastrointestinal mucosal resection procedures.

REPORT COVERAGE OF ENDOSCOPIC MUCOSAL RESECTION MARKET

The Endoscopic Mucosal Resection Market Report provides a comprehensive assessment of market structure, technological developments, competitive landscape, product innovations, and healthcare adoption patterns across major regions. The report evaluates market performance using qualitative and quantitative indicators while examining trends influencing gastrointestinal therapeutic procedures. The study analyzes segmentation by product type, including entry needles, mucosectomy snares, probes, and supporting accessories. It also evaluates application areas across hospitals, ambulatory surgical centers, and surgical centers, highlighting procedure volumes, technology adoption, and equipment utilization. Approximately 55% of market demand originates from hospitals, while outpatient facilities account for nearly 30% of procedure volumes.

Regional analysis covers North America, Europe, Asia-Pacific, and the Middle East & Africa, providing detailed insights into healthcare infrastructure, physician availability, technological adoption, and screening program expansion. The report also profiles major manufacturers, comparing product portfolios, innovation strategies, and competitive positioning. Additionally, the Endoscopic Mucosal Resection Market Research Report examines investment trends, regulatory developments, new product launches, technological advancements, and strategic partnerships shaping the industry. Approximately 50% of recent innovations focus on improved visualization systems, disposable therapeutic accessories, and AI-assisted endoscopy technologies. The report serves as a valuable resource for manufacturers, healthcare providers, investors, distributors, procurement professionals, and decision-makers seeking comprehensive Endoscopic Mucosal Resection Market Insights, Market Forecast, Market Share, and Industry Analysis.